Clinical Trial Update: Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy [Phase 1]

View source ↗

Summary

Phase 1 trial results assessing the safety and preliminary efficacy of AIV001 to reduce scar formation and prevent keloid recurrence after keloidectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloid
• Scar

Drugs mentioned

• AIV001

Snippet

Sponsor: AiViva BioPharma, Inc. | Conditions: Keloid, Scar | Phase 1 | Status: COMPLETED